Acquiring Company
BioNTech
Acquired Company
Biotheus
Mainz
ZhuhaiBiotechnologyHealth CareTherapeuticsBiopharmaBiotechnologyHealth CareMedicalTherapeuticsDescription
BioNTech SE has successfully completed the acquisition of Biotheus, a clinical-stage biotechnology company based in China. This acquisition reinforces BioNTech's commitment to advancing its oncology strategy, enhancing the company's capabilities in researching, developing, and commercializing innovative pan-tumor technology platforms for the treatment of advanced cancers. The strategic acquisition also establishes Biotheus as a new indirect Chinese subsidiary of BioNTech, providing access to local research and development resources, and an advanced biologics manufacturing facility.
Who to call at BioNTech, and when
When BioNTech changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day BioNTech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioNTech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioNTech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioNTech makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Biotheus?
Biotheus was acquired by BioNTech, based in Mainz. The deal was reported on February 4, 2025. BioNTech is a biopharmaceutical company dedicated to harnessing the power of the immune system to develop innovative cancer therapies and treatments for other serious diseases. BioNTech is publicly traded (BNTX) and operates in Biotechnology.
When did BioNTech acquire Biotheus?
BioNTech's acquisition of Biotheus was reported on February 4, 2025. BioNTech SE has successfully completed the acquisition of Biotheus, a clinical-stage biotechnology company based in China. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Biotheus do?
Biotheus is a clinical-stage biotechnology company dedicated to the discovery and development of novel antibodies to address unmet medical needs of patients with oncological or inflammatory diseases. It is privately held, operating in Biotechnology, and is based in Zhuhai.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.